[
    [
        {
            "time": "2020-12-31",
            "original_text": "上海医药(02607.HK)拟计提商誉减值准备4.86亿元 资产异常",
            "features": {
                "keywords": [
                    "上海医药",
                    "商誉减值",
                    "计提",
                    "4.86亿元",
                    "资产异常"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上海医药(02607.HK)拟计提商誉减值准备4.86亿元 资产异常",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "因计提商誉减值准备 上海医药(601607.SH)2020年度归母净利减少约4.78亿元 资产异常",
            "features": {
                "keywords": [
                    "上海医药",
                    "商誉减值",
                    "计提",
                    "4.78亿元",
                    "归母净利",
                    "资产异常"
                ],
                "sentiment_score": -0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "因计提商誉减值准备 上海医药(601607.SH)2020年度归母净利减少约4.78亿元 资产异常",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "上海医药(601607.SH)：拟计提商誉减值准备金额合计约4.86亿元 资产异常",
            "features": {
                "keywords": [
                    "上海医药",
                    "商誉减值",
                    "计提",
                    "4.86亿元",
                    "资产异常"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上海医药(601607.SH)：拟计提商誉减值准备金额合计约4.86亿元 资产异常",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "上海医药：拟计提2020年商誉减值准备4.86亿元 资产异常",
            "features": {
                "keywords": [
                    "上海医药",
                    "商誉减值",
                    "计提",
                    "2020年",
                    "4.86亿元",
                    "资产异常"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上海医药：拟计提2020年商誉减值准备4.86亿元 资产异常",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]